[HTML][HTML] COVID-19 update: the first 6 months of the pandemic
G Novelli, M Biancolella, R Mehrian-Shai, C Erickson… - Human genomics, 2020 - Springer
The COVID-19 pandemic is sweeping the world and will feature prominently in all our lives
for months and most likely for years to come. We review here the current state 6 months into …
for months and most likely for years to come. We review here the current state 6 months into …
[HTML][HTML] Mesenchymal stem cells for the compassionate treatment of severe acute respiratory distress syndrome due to COVID 19
M Iglesias, P Butrón, I Torre-Villalvazo… - Aging and …, 2021 - ncbi.nlm.nih.gov
Mesenchymal stem cells (MSC) have received particular attention due to their ability to
inhibit inflammation caused by cytokine storm induced by COVID-19. In this way some …
inhibit inflammation caused by cytokine storm induced by COVID-19. In this way some …
[HTML][HTML] Need for a standardized translational drug development platform: Lessons learned from the repurposing of drugs for COVID-19
F Assmus, JS Driouich, R Abdelnabi, L Vangeel… - Microorganisms, 2022 - mdpi.com
In the absence of drugs to treat or prevent COVID-19, drug repurposing can be a valuable
strategy. Despite a substantial number of clinical trials, drug repurposing did not deliver on …
strategy. Despite a substantial number of clinical trials, drug repurposing did not deliver on …
[HTML][HTML] Remdesivir analog as SARS-CoV-2 polymerase inhibitor: virtual screening of a database generated by scaffold replacement
By the end of 2019, a novel strain of the corona viral family named SARS-CoV-2 emerged in
Wuhan, China and started to spread worldwide causing one of the most dangerous lethal …
Wuhan, China and started to spread worldwide causing one of the most dangerous lethal …
An Insight into the Symptomatic Treatment Modalities for COVID-19
G Sawhney, P Kumar, SP Parihar… - RNA Viruses and …, 2023 - taylorfrancis.com
In late December 2019, an outbreak of novel coronavirus disease 2019 (COVID-19)
emerged in Wuhan, China, and spread throughout the world very quickly. COVID-19 is a …
emerged in Wuhan, China, and spread throughout the world very quickly. COVID-19 is a …
A Review on Utilisation of Remdesivir in TreatingCovid–19: Therapeutic Repurposing and Unmet Clinical Needs
S SOMALA, Y Bhavani, S Salma - International Journal of Pharmacy …, 2022 - ijprt.org
Remdesivir is the first drug that has been approved by the US Food and Drug Administration
(FDA) for clinical use in hospitalized patients with COVID-19 illness. Remdesivir is a broad …
(FDA) for clinical use in hospitalized patients with COVID-19 illness. Remdesivir is a broad …
Remdesivir analog as SARS-CoV-2 polymerase inhibitor: virtual screening of a database generated by scaffold replacement
A Albohy, MA Said, MA Abdelrahman, H Said - 2022 - buescholar.bue.edu.eg
By the end of 2019, a novel strain of the corona viral family named SARS-CoV-2 emerged in
Wuhan, China and started to spread worldwide causing one of the most dangerous lethal …
Wuhan, China and started to spread worldwide causing one of the most dangerous lethal …